Chlormezanone

This image is provided by the National Library of Medicine.

WikiDoc Resources for Chlormezanone
Articles
Most recent articles on Chlormezanone Most cited articles on Chlormezanone Review articles on Chlormezanone Articles on Chlormezanone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Chlormezanone Images of Chlormezanone Photos of Chlormezanone Podcasts & MP3s on Chlormezanone Videos on Chlormezanone
Evidence Based Medicine
Cochrane Collaboration on Chlormezanone Bandolier on Chlormezanone TRIP on Chlormezanone
Clinical Trials
Ongoing Trials on Chlormezanone at Clinical Trials.gov Trial results on Chlormezanone Clinical Trials on Chlormezanone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Chlormezanone NICE Guidance on Chlormezanone NHS PRODIGY Guidance FDA on Chlormezanone CDC on Chlormezanone
Books
Books on Chlormezanone
News
Chlormezanone in the news Be alerted to news on Chlormezanone News trends on Chlormezanone
Commentary
Blogs on Chlormezanone
Definitions
Definitions of Chlormezanone
Patient Resources / Community
Patient resources on Chlormezanone Discussion groups on Chlormezanone Patient Handouts on Chlormezanone Directions to Hospitals Treating Chlormezanone Risk calculators and risk factors for Chlormezanone
Healthcare Provider Resources
Symptoms of Chlormezanone Causes & Risk Factors for Chlormezanone Diagnostic studies for Chlormezanone Treatment of Chlormezanone
Continuing Medical Education (CME)
CME Programs on Chlormezanone
International
Chlormezanone en Espanol Chlormezanone en Francais
Business
Chlormezanone in the Marketplace Patents on Chlormezanone
Experimental / Informatics
List of terms related to Chlormezanone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Chlormezanone (marketed under the brandname Trancopal or Fenaprim) is a drug used as an anxiolytic and a muscle relaxant. Its use was discontinued in many countries from 1996 on, due to rare but serious cases of toxic epidermal necrolysis.

Chemistry

This image is provided by the National Library of Medicine.

References

• Wollina U, Hipler U, Seeling A, Oelschlager H (2005). "Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro". Skin Pharmacol Physiol. 18 (3): 132–138. doi:10.1159/000084910. PMID 15897685.CS1 maint: Multiple names: authors list (link)
• Seeling A, Oelschläger H, Rothley D (2000). "Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone". Pharmazie. 55 (4): 293–6. PMID 10798243.CS1 maint: Multiple names: authors list (link)
• Oelschläger H, Klinger W, Rothley D, Seeling A, Bockhard H, Hofmann B, Machts H, Riederer H, Rackur H (1998). "[Cleavage and biotransformation of the central muscle relaxant chlormezanone]". Pharmazie. 53 (9): 620–4. PMID 9770210.CS1 maint: Multiple names: authors list (link)
• Gautier V, Vincon G, Demotes-Mainard F, Albin H (1990). "[Pharmacokinetics of chlormezanone in healthy volunteers] (original in French)". Pharmazie. 45 (4): 315–9. PMID 2399514.CS1 maint: Multiple names: authors list (link)